Food & Health
Law & Insurance
Nano & Biomaterials
Markets & Trends
Welcome to the
European Life Science Journal for international business
Get inspired by the entrepreneurs leading the way of tomorrow´s life science businesses !
GeneReach- from samples to results, your one-stop solution for mulecular diagnostics is looking for distributors
GeneReach Biotechnology Corporation (GeneReach), founded in 1993, is a supplier of viral and genetic diagnosis products. Since 1995, we have focused our R&D on viral diagnosis associated with aquaculture species, especially penaeid shrimps and salt water fishes. At GeneReach, we provide not only the reagents for diagnosis but also full technical support programs for our products. After suc...
Adenovir Pharma: Innovation for eye infections
Epidemic keratoconjunctivitis (EKC) is a highly contagious eye infection caused by a number of different adenoviruses. Symptoms include conjunctivitis, keratitis, tearing, pain and discomfort, and ...
China placing priority on biotechnology
China will spend 2 trillion yuan ($308.5 billion) on science and technology, making biotechnology a major priority, in the next five years, Chinese State Councilor Liu Yandong said at the ong...
Stem cell technology used in unique surgery in Gothenburg
Prof. Michael Olausson, responsible for the unique surgery at Sahlgrenska University Hospital.Photo: Björn Larsson RosvallFor the first time ever in the world, researchers at the Sahlgrenska ...
Nordiag and Molzym enter into first sepsis agreement
Sepsis is one of the leading cause of death in hospitals world-wide. On March 17, it was announced that Molzym has entered into an agreement with Seegene for delivery of reagents based on their mol...
Vironova leads Flucure project
TEM image of influenza virus The Swedish biotech company developing novel antiviral therapeutics and virus diagnostics, Vironova, leads a new influenza drug development programme with EU fundi...
Lorus Therapeutics Enrolls First Patient in Phase I Clinical Study of Anticancer Drug LOR-253
TORONTO, ONTARIO--(Marketwire - Jan. 13, 2011) - Lorus Therapeutics Inc. (TSX:LOR)(OTCBB:LRUSF) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development ...
Cutting costs must not hamper innovation
Biotech companies worldwide reported a profit in 2009 for the first time since 1985 as revenues increased and spending on R&D was cut.ECONOMIC OUTLOOK: A report recently published by Erns...
Making personal medicine a reality
BlackBiostarted as a new entity, based upon a revolutionary development achieved by itsfounding team, by converting the until now little known Pyrosequencingtechnology into the spotlight for ...
Spanish biotech industry exceeds EUR 30 billion in revenue
The Spanish BioindustryAssociation’s annual report shows that investments in R&D have been doubledin three years, up to UER 460 million in 2008 and that internationalisation is,for the fi...
Higher quality and efficient bioanalytical service at Quotient Bioresearch
Quotient Bioresearch is a fast growing contract research organisation that brings together well-known specialists in radiochemistry, metabolism, bioanalysis and biomarkers, early phase clinical res...
Consolidated CRO connects east and west
SBW Ltd is well-positioned to handle the restructuring of the pharma industry, where both India and China are becoming all the more important destinations for pharma research and development....